HIV Prevention
Conditions
Brief summary
To assess the acceptability of a user-filled, paper, applicator for delivery of tenofovir (TFV) gel among women at high risk of acquiring human immunodeficiency virus (HIV) in rural KwaZulu-Natal, South Africa.
Detailed description
CAPRISA 070 is designed to enroll rural women who exit from CAPRISA 008 - an ongoing trial assessing implementation, effectiveness and safety of TFV gel in KwaZulu-Natal, South Africa. All study participants in CAPRISA 008 have also participated in CAPRISA 004 and thus have several years of experience using TFV gel with the prefilled, plastic applicator. CAPRISA 070 will allow us to assess acceptability of the user-filled, paper applicator among women who have had extensive experience with the pre-filled, plastic applicator and are well-positioned to provide feedback and comparisons on a new gel delivery method.
Interventions
DRUGTFV 1% gel
Sponsors
CONRAD
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Age 18 years and older * Women who previously participated in CAPRISA 008 * Able and willing to provide first person informed consent to be screened for, and to enroll in, the study * Allow access to their CAPRISA 008 data, including study exit data * Able and willing to provide adequate locator information for study retention purposes * Sexually active (at least one coital act in the last 3 months prior to screening) * HIV negative * Negative pregnancy test \* * Agree to use a non-barrier form of contraceptive * Agree to adhere to study visits and procedures * breastfeeding is not exclusionary but participants must be informed of the presence of TFV in breast milk in negligible amounts
Exclusion criteria
* Has creatinine clearance ,\<50ml/min, as estimated using the method of Cockcroft and Gault * Has any other condition, that based on the opinion of the investigator or designee would preclude provision of informed consent, make participation in the study unsafe, complicate interpretation of the study outcome data, or otherwise interfere with achieving the study objectives
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Overall acceptability | over 3 months of use | Overall acceptability of user-filled, paper applicator compared to prefilled, plastic applicator |
| context of use | over three months | Description of context of use of user-filled, paper applicator |
| challenges encountered | over three months | Challenges encountered during use of user-filled, paper applicator and recommendations to address challenges |
| Applicator Preference | Over three months | Applicator preferences between the user-filled, paper applicator and prefilled, plastic applicator |
Countries
South Africa
Outcome results
None listed